cetrimide + lidocaine hydrochloride monohydrate + zinc sulfate: prescribing and clinical use
Focused clinical detail for use alongside current product information, local policy and patient-specific assessment.
cetrimide + lidocaine hydrochloride monohydrate + zinc sulfate: clinical details
Prescribing considerations
- Confirm that symptoms follow an insect bite, sting or plant-contact reaction; this product is not suitable for animal bites.
- Cutaneous use only; not recommended below 12 years because data are insufficient.
- Propylene glycol may cause skin irritation.
Contraindications and cautions
- Known hypersensitivity to any active substance or excipient
Monitoring
- No product-specific laboratory monitoring is specified.
- Review if irritation, sensitisation, worsening symptoms or other unwanted effects occur.
Clinical pharmacology
Lidocaine is an amide local anaesthetic that inhibits sensory impulse conduction. Cetrimide is a quaternary ammonium antiseptic, while zinc sulfate provides astringent and soothing activity. The product acts locally; lidocaine absorption is slower through intact skin than through mucous membranes.
Formulation and product differences
- The licence covers a colourless, viscous gel with a menthol odour marketed under Bites & Stings Pain Relief Gel and Antiseptic and Pain Relief Gel names.
cetrimide + lidocaine hydrochloride monohydrate + zinc sulfate interactions
No interactions with other medicines are known.
Sources
These sources were used to prepare and review this medicine page.
Prepared and reviewed by the iatroX editorial team.